It is important to set appropriate start and end dates for the MTA and any permitted uses. Once again this might be tied to the purpose of the MTA. It is possible that the end of the agreement might be marked by an activity, rather than a date - for example, the completion of the intended purpose, or the provision of a final report.
It is essential to provide which rights and obligations will survive the termination of the MTA, including for example confidentiality clauses, publications or release of data into the public domain, as well as licenses or agreements for further use.
It is also important to consider the events that could cause an early termination of the agreement, for example, the merger of the recipient laboratory with another laboratory, if the laboratory is found unable to meet regulatory requirements, or the laboratory simply ceases its operations.
This is where the nominated and authorised individuals sign the agreement on behalf of their relative institutions or organizations. It may also be desirable to have the lead researcher co-sign the MTA to ensure that they are aware of and understand the associated obligations and conditions.